Specifically, Pro-uPA secreted by tumor cells binds to uPAR to activate uPA, which then activates plasminogen bound to the cell surface, converting it into plasmin and degrading tumor cell connections, including laminin, fibrin, fibronectin, and other substrates [68]. The gene discussed is FN1; the disease is neoplasm.